Regulatory T (Treg) cells are essential for maintaining peripheral tolerance and for limiting excessive inflammatory responses under various conditions. The lineage-specific transcription factor Foxp3 has a critical role in Treg-cell biology. Foxp3 forms large protein complexes and cooperates with environmentally induced transcription factors to shape the Treg-cell transcriptional program. Here, we discuss mechanisms of gene regulation that underlie Treg-cell differentiation and function with an emphasis on studies from our laboratory.
Regulatory T (Treg) cells are a subset of CD4 T cells defined by stable expression of the lineage-specific transcription factor Foxp3 and immunosuppressive function. Under homeostatic conditions, Treg cells are present in primary and secondary lymphoid organs as well as in various nonlymphoid tissues such as the liver, lung, intestine, and adipose tissue. Treg cells have a critical role in suppression of inflammatory responses in a variety of biological contexts and are essential for maintaining selftolerance throughout life. Systemic depletion of Treg cells in mice leads to lympho-and myelo-proliferative disease and lethal autoimmunity, mediated by autoreactive effector CD4 T cells (Kim et al. 2007) . Abnormal Treg-cell function has been implicated in many human autoimmune diseases, including Type I diabetes, rheumatoid arthritis, multiple sclerosis, and lupus (Buckner 2010) . Treg cells are also present in many solid tumors where they dampen antitumor immune responses. Transient ablation of Treg cells in this context can enhance tumor clearance (von Boehmer and Daniel 2013) .
The suppressive function of Treg cells is enabled by high-level expression of multiple inhibitory molecules, including CD39, CD73, TIGIT, IL-10, cytolytic effector molecules, IL-10, and TGF-b ). Importantly, elaboration of effector T-cell functions such as production of proinflammatory cytokines is repressed in Treg cells. Another important hallmark of Treg cells is their requirement for interleukin-2 (IL-2) as an essential differentiation and growth factor (Fontenot et al. 2005b) . In contrast to conventional CD4 T cells, Treg cells constitutively express the high-affinity IL-2 receptor a chain CD25 but lack the ability to produce IL-2. Therefore, these cells rely entirely on paracrine IL-2 produced by activated effector T cells for their survival. Treg cells may also use their characteristically high amounts of CD25 to limit the proliferation of neighboring effector T cells by acting as a sink for IL-2 (Pandiyan et al. 2007 ).
Foxp3 has a critical role in establishing and maintaining the transcriptional and functional programs of Treg cells. Loss-of-function mutations in the Foxp3 gene in mice or humans result in Treg-cell dysfunction and fatal multiorgan autoimmune disease similar to that observed in mice after systemic ablation of all Foxp3-expressing cells (Chatila et al. 2000; Bennett et al. 2001; Brunkow et al. 2001; Wildin et al. 2001; Fontenot et al. 2003; Hori et al. 2003; Khattri et al. 2003) . Continued Foxp3 protein expression is essential for the maintenance of Treg-cell fate, because induced Foxp3 deficiency in mature Treg cells leads to a loss of their suppressive function and fitness (Williams and Rudensky 2007) .
This review is focused on the multistage differentiation process that gives rise to stable functionally competent Treg cells. Specifically, we discuss a Foxp3-independent program that controls much of the Treg-cell surface phenotype and Foxp3 induction, directed by multiple regulatory elements within the Foxp3 gene locus. Finally, we summarize recent studies by our laboratory and others of epigenetic mechanisms that afford stable expression of the Foxp3 gene and a role for Foxp3 protein complexes in establishing a repressive epigenetic program.
FOXP3-INDEPENDENT PROGRAM OF TREG-CELL DIFFERENTIATION
During T-cell maturation, Treg-cell differentiation can be initiated in either thymic or peripheral precursor cells. TCR-peptide-MHC interactions have a critical role in both thymic and extrathymic Treg-cell differentiation; however, requirements for specific accessory stimuli, such as cytokines or small molecules, are likely different. Thymic Treg cells (tTreg cells) differentiate upon induction of Foxp3 in maturing CD4 single positive progenitors in the thymic medulla (Fontenot et al. 2005a ). Peptide-MHC -TCR interactions have an instructive role at this stage of development. Specifically, thymocytes expressing TCRs with a relatively high affinity for self-peptides are selected into the Treg-cell lineage (Lee et al. 2012) . The minimum TCR signal strength required for Treg-cell differentiation is below the threshold for negative selection and also below the threshold for T-cell activation in the periphery. This requirement may be directly linked to the biological function of tTreg cells in exerting dominant tolerance, because it would ensure that generation of autoreactive conventional CD4 T cells that escape negative selection is accompanied by generation of Treg cells that can suppress their activation. Generation of extrathymically or peripherally induced Treg cells ( pTreg cells) from conventional naive CD4 T-cell precursors also requires TCR activation. Weak TCR stimulation by a low-density, high-affinity ligand in the context of suboptimal costimulation seems to favor pTreg-cell generation (Kretschmer et al. 2005; Benson et al. 2007; Gottschalk et al. 2010) . However, the impact of variations in these parameters is markedly reduced in the presence of tolerogenic environmental cues, such as TGF-b and retinoic acid, which allow efficient pTreg-cell generation over a wider range of TCR stimulation strengths (Benson et al. 2007; Gottschalk et al. 2010 ). These relaxed requirements for TCR signal strength likely reflect the biological function of pTreg cells-providing tolerance to antigens sparsely represented or lacking in the thymus, including those derived from food and commensal microbiota, which are typically encountered under tolerogenic conditions. TCR activation has an essential role in establishing the Foxp3-independent aspects of the Treg-cell transcriptional program. Analysis of Treg precursor cells expressing a Foxp3 GFPKO reporter-null allele, in which the GFP coding sequence is inserted into the Foxp3 locus with concomitant disruption of Foxp3 expression, shows that a large portion of the Treg-cell transcriptional signature is independent of Foxp3 Lin et al. 2007 ). Many of the genes that are typically expressed at constitutively high levels in Treg cells are largely Foxp3 independent and are also induced, albeit transiently and at a lower level, in conventional Foxp3-negative CD4 T cells following TCR stimulation Hill et al. 2007; Lin et al. 2007 ). These include CD25, CTLA4, GITR, and Ikzf2 (Helios). The requirement for paracrine IL-2 for Treg-cell survival is also established independently of Foxp3 expression; however, suppressive function of Treg cells and their in vivo fitness are Foxp3 dependent Lin et al. 2007) .
The idea that TCR activation has a critical Foxp3-independent role in Treg-cell differentiation is further supported by analysis of chromatin accessibility and epigenetic modifications in Treg cells and their precursors. Establishment of Treg-cell-specific DNA methylation patterns occurs in the absence of Foxp3 and is driven by TCR stimulation (Ohkura et al. 2012) . Moreover, much of the enhancer repertoire of Treg cells, revealed by genome-wide analysis of DNase I -sensitive sites, is already present in naive CD4 T cells or can be induced upon TCR stimulation in a Foxp3-independent manner (Samstein et al. 2012a ). These regulatory elements are enriched for the DNA-binding motifs of major transcription factors activated downstream from the TCR such as AP1 and CREB. These results suggest that TCR activation during early stages of Treg-cell differentiation induces part of the Treg-cell transcriptional program and establishes the chromatin landscape upon which Foxp3 later acts.
How exactly thymocytes interpret moderately strong TCR signals to become Treg cells, rather than undergo apoptosis or differentiation into conventional CD4 T cells, remains unclear. Nevertheless, this process is likely controlled by transcription factors downstream from the TCR, whose expression level or activity can be modulated by TCR signal strength or duration. Nr4a family transcription factors appear to have a key role in this process because their expression level in thymocytes is directly proportional to TCR signal strength (Moran et al. 2011) . Furthermore, genetic ablation of these factors causes impaired Treg-cell generation and lethal autoimmunity (Sekiya et al. 2013) . Conversely, retroviral overexpression of Nr4a family members leads to either Foxp3 induction or apoptosis, depending on the expression level. Consistent with their ability to promote Foxp3 expression, chromatin immunoprecipitation (ChIP) studies showed that Nr4a family members bind to the Foxp3 regulatory elements. Thus, these factors likely translate TCR signal strength to Treg-cell lineage fate decisions in thymic precursors.
Despite its critical role in Treg-cell differentiation, TCR activation alone may not be sufficient to induce the full Foxp3-independent transcriptional program. A subset of Treg-specific genes expressed in Treg cells and Foxp3 GFPKO Treg precursors cannot be induced by TCR activation or ectopic retroviral expression of Foxp3 in conventional CD4 T cells Hill et al. 2007; Lin et al. 2007 ). These observations implicate an as-of-yet undiscovered regulatory network in establishment of a part of the Foxp3-independent Treg transcriptional program. In addition to the TCR, several additional external stimuli, including common g chain cytokines, TGF-b, TNF receptor family members, and costimulatory ligands, acting upon Treg-cell precursors before and after Foxp3 expression, contribute to the efficient generation of Treg cells in the thymus and peripheral lymphoid organs. These signaling pathways may contribute to Treg-cell differentiation in multiple ways, including induction and maintenance of Foxp3 expression, promotion of Treg precursor survival after strong TCR stimulation, and regulation of cell cycle and population expansion ). The direct role of these signals in shaping the Foxp3-independent transcriptional program and chromatin landscape is still not fully understood.
REGULATION OF FOXP3 INDUCTION
Many of the same signals that establish the Foxp3-independent enhancer repertoire and transcriptional program may also control Foxp3 induction by converging on regulatory DNA elements in the Foxp3 locus. In addition to the promoter, three conserved noncoding sequence elements (CNS1, 2, and 3) that contribute to Foxp3 gene regulation have been identified so far (Zheng et al. 2010) .
Based on the analysis of permissive histone modifications, the CNS3 element is the earliest accessible regulatory region in the Foxp3 locus. It is accessible at early stages of thymocyte development and remains open in mature CD4 T cells and differentiated Treg cells. Genetic disruption of CNS3 markedly reduces the efficiency of both thymic and peripheral Treg-cell generation. Interestingly, CNS3-deficient Treg cells express normal levels of Foxp3, and CNS3 does not enhance Foxp3 promoter activity in luciferase reporter assays (Zheng et al. 2010) . We propose that rather than directly boosting Foxp3 expression, CNS3 may initiate epigenetic remodeling of the Foxp3 locus in Treg precursors and increase their sensitivity to Foxp3-inducing signals. So far, the only transcription factors that have been shown to bind to CNS3 are NFkB family members, including c-Rel, p50, and IkB NS (Zheng et al. 2010; Schuster et al. 2012) , whose activity or expression is induced upon TCR activation. These factors are required to promote efficient Foxp3 induction in Treg precursors in a cell intrinsic manner. Thus, during Foxp3 induction NF-kB family transcription factors may act through CNS3 to control Foxp3 induction efficiency (Zheng et al. 2010; Schuster et al. 2012) .
The Foxp3 promoter is bound by multiple transcription factors that are known to be required for thymic Treg-cell differentiation, including CREB, NFAT, STAT5, Foxo1, Foxo3a, Nr4a, and NFkB family members (Burchill et al. 2007; Ruan et al. 2009; Harada et al. 2010; Ouyang et al. 2010; Sekiya et al. 2013) . Although some of these factors can activate the Foxp3 promoter in an in vitro luciferase reporter assay, their direct contribution to Foxp3 gene activation in vivo is still unclear. These factors have important roles in regulating T-cell homeostasis and bind to thousands of regulatory elements genome wide. Targeted mutagenesis of their putative binding sites within the Foxp3 promoter and enhancer elements combined with an assessment of the occupancy of these sites may help to clarify this issue. However, the emerging view that cooperative occupancy of key regulatory elements with multiple transcription factors is required for modulation of a given gene and that multiple genes and regulatory elements can physically interact and be coregulated could complicate the interpretation of these experiments Glasmacher et al. 2012; Li et al. 2012; de Laat and Duboule 2013) .
In addition to the Foxp3 promoter and CNS3, generation of pTreg cells requires the activity of an additional regulatory element, CNS1. In vitro and in vivo Foxp3 induction in naive CD4 T-cell precursors is impaired in mice lacking CNS1, whereas the frequency and function of thymic Treg cells is unaffected (Zheng et al. 2010) . CNS1 is bound by several transcription factors downstream from signaling pathways implicated in pTreg-cell generation, including NF-kB family members, CREB, AP-1, NFAT, Smad3, and RAR/RXR (Tone et al. 2008; Ruan et al. 2009; Xu et al. 2010) . Similarly to the uncertain relative contribution of some of these transcription factors to Foxp3 promoter activity, it is still unclear to what extent their function in extrathymic Foxp3 induction is actually dependent on engagement of CNS1, with a notable exception for Smad3. The significance of TGFb-induced Smad3 binding to CNS1 has been directly investigated in mice lacking the Smad3-CNS1 binding site (Schlenner et al. 2012) . Loss of Smad3 binding to CNS1 leads to impaired in vitro Foxp3 induction efficiency and reduced Treg-cell frequency in the gut-associated lymphoid tissues in aged mice, albeit to a considerably lesser degree than CNS1 deficiency. These results suggest that Smad3 binding to CNS1 directly contributes to Foxp3 induction in pTreg cells in cooperation with other sequence-specific transcription factors that are still capable of supporting "attenuated" pTreg generation in the absence of Smad binding.
STABILIZATION OF FOXP3 EXPRESSION
Continuous Foxp3 expression in Treg cells is required to maintain suppressive function and cellular fitness and prevents acquisition of effector T-cell characteristics. Based on in vivo lineage tracing studies using inducible Treg-specific Cre recombinase expression combined with a ROSA-YFP recombination reporter (Foxp3 GFP-Cre-ERT2
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fl-STOP-YFP mice), the majority Treg cells stably maintain Foxp3 expression under steady-state physiologic or inflammatory conditions (Rubtsov et al. 2010 ). These observations are consistent with the analysis of Treg stability using adoptive transfers of Treg cells expressing a Foxp3 reporter allele (Miyao et al. 2012 ). Thus, Treg-cell lineage stability is acquired in the process of Treg-cell differentiation after a period of instability when some maturing extrathymically generated Treg-cell precursors can lose Foxp3 expression. Although it is not clear whether a comparable or lesser loss of Foxp3 expression might occur in thymic Treg-cell precursors, these findings implicate a dedicated mechanism that ensures stability of Foxp3 expression and, therefore, of the Treg-cell lineage. We found that another regulatory element in the Foxp3 locus CNS2 has a dedicated role in conferring Treg-cell lineage stability. CNS2 does not regulate induction of Foxp3 or its expression level on a per-cell basis. It is also dispensable for the maintenance of Foxp3 expression in resting Treg cells but is required for heritable maintenance of Foxp3 expression in the progeny of dividing Treg cells (Zheng et al. 2010 ). CNS2 contains a CpG island that is fully methylated in Treg-cell precursors. Thymic Treg cells gradually demethylate CNS2 during their maturation, in parallel with establishment of the Treg transcriptional program (Toker et al. 2013) . This is reminiscent of the aforementioned acquisition of stability by in vivo-generated extrathymically induced pTreg cells over time ). Importantly, in vitro induction of Foxp3 expression through naive T-cell activation in the presence of TGF-b does not result in CNS2 demethylation, and these cells can readily lose Foxp3 expression after restimulation (Polansky et al. 2008 ). Similarly, human CD4 T cells transiently express low levels of Foxp3 following TCR stimulation, while maintaining CNS2 in a methylated state (Gavin et al. 2006; Allan et al. 2007; Tran et al. 2007; Wang et al. 2007; Nagar et al. 2008 ). These cells do not acquire suppressive function and lose Foxp3 expression over time. A population of Foxp3 low Treg cells with similar characteristics can be detected in human peripheral blood (Miyara et al. 2009 ). Although the activity of CNS2, as measured by its CpG methylation status, has been widely used as an indicator of Treg lineage commitment (Polansky et al. 2008) , the question remains as to whether methylated CNS2 has a role in Foxp3 expression or becomes active only upon demethylation. Despite remaining mechanistic issues, these studies suggest that induction and stabilization of Foxp3 expression are separate events that require distinct signals and are subject to distinct means of control.
Several transcription factors that are essential for Treg stability have been shown to bind CNS2, including Runx, Foxp3, and STAT5. Deletion of a conditional allele of Cbfb (core binding factor b), an essential cofactor of Runx family transcription factors, in Treg cells causes progressive loss of Foxp3 expression (Rudra et al. 2009 ). Runx/Cbfb protein complexes bind to demethylated CNS2 and recruit Foxp3 to this site (Zheng et al. 2010 ). Similar to Cbfb-deficient Treg cells, Foxp3 GFPKO -expressing cells fail to maintain transcriptional activity of the Foxp3 locus during homeostatic expansion, suggesting that Foxp3 has a role in maintaining its own expression ). Yet, CNS2 demethylation does not require functional Foxp3 protein Ohkura et al. 2012) , and it is still unknown whether CNS2 deficiency could further destabilize Foxp3 gene transcription in the absence of functional Foxp3 protein.
Another important contributor to Treg-cell stability is STAT5. In vivo deprivation of IL-2, the key Treg-cell growth factor and STAT5-activating cytokine, induces loss of Foxp3 expression in some Treg cells (Rubtsov et al. 2010) . Conversely, strong STAT5 stimulation through administration of IL-2-anti-IL-2 immune complexes stabilizes Foxp3 expression in adoptively transferred in vitro -generated Treg cells (Chen et al. 2011) . Although STAT5 can bind to CNS2, it is still unknown whether this binding is methylation dependent. Together, these findings indicate that maintenance of Foxp3 expression and Treg-cell lineage stability are intertwined with Treg-cell proliferation and survival and critically dependent on IL-2.
FOXP3-DEPENDENT PROGRAM OF TREG DIFFERENTIATION
Although a large part of the Treg-cell chromatin landscape and transcriptional program is established before its expression, Foxp3 as a late-acting factor is critical for Treg-cell lineage specification. Accordingly, as we discuss above, Foxp3 deficiency causes the same severe autoimmunity as systemic Treg-cell depletion. The functional significance of Foxp3 expression in Treg cells has been illuminated by studies of mice harboring a Foxp3 GFPKO reporter-null allele. GFP-expressing cells from these mice lack the capacity to suppress effector Tcell activation and expansion and acquire the ability to produce proinflammatory cytokines upon stimulation Lin et al. 2007) . In contrast to wildtype Treg cells, Foxp3 GFPKO -expressing cells fail to maintain transcriptional activity of the Foxp3 locus during homeostatic expansion upon transfer to a lymphopenic host and are outcompeted by Foxp3
þ Treg cells when present in the same mouse. Thus, Foxp3 is essential for the suppressive function, lineage stability, and in vivo maintenance of Treg cells. Deletion of a loxp-flanked Foxp3 allele in fully differentiated Treg cells results, in addition to a loss for suppressor function, in acquisition of effector T-cell phenotype, that is, production of proinflammatory cytokines and pathogenic potential due to heightened selfreactivity of Treg cells (Williams and Rudensky 2007) . This indicates that expression of Foxp3 is not just transiently required for early Treg-cell lineage commitment but continues to be essential in mature Treg cells.
The combination of gene expression, genome-wide Foxp3-binding site, and chromatin state analyses in Treg and precursor cells has provided important insights into the mechanisms of Foxp3-mediated gene regulation. Foxp3-bound enhancers that are either preaccessible in naive Foxp3-negative Treg precursors or rendered accessible following TCR activation during Foxp3 induction are enriched for the DNA-binding motifs of CREB and AP1, major transcription factors downstream from the TCR that can enhance chromatin accessibility (Samstein et al. 2012a ). Thus, Foxp3 does not establish a unique set of cell-type-specific enhancers but acts upon a TCR-dependent preformed enhancer landscape. Interestingly, essential lineage-specifying transcription factors in other CD4 T-cell subsets seem to operate in a similar manner. During Th1 differentiation, the cytokine signaling activated transcription factors STAT1 and STAT4 activate a subset of lineage-specific enhancers from a greater TCRinduced latent enhancer repertoire to establish the Th1-specific chromatin landscape. This preformed landscape is occupied by the Th1 lineage-specifying transcription factor T-bet, which does not seem to significantly contribute to formation of the Th1 enhancer repertoire (Vahedi et al. 2012) . Similarly, in Th17 cells the lineage-specifying transcription factor RORgt binds to preaccessible regulatory regions that are occupied by TCR-induced transcription factors BATF and IRF4 Glasmacher et al. 2012; Li et al. 2012) . Thus, Foxp3, like T-bet, and RORgt, seems to act relatively late in the Treg-cell differentiation process to fine-tune a TCR and cytokine-induced program of gene expression.
How does Foxp3 regulate its target gene expression? A comparison of Foxp3-bound genes in Treg cells to naive CD4 T cells in unchallenged healthy mice showed that Foxp3-bound sites are found among both up-and downregulated genes in Treg cells. This seems to indicate that Foxp3 can act as either an activator or repressor of gene expression . However, this analysis may be confounded by the differential activation state of the two cell types. In contrast to conventional naive CD4 T cells, Treg cells have received strong TCR stimulation during their thymic or extrathymic differentiation and may be continuously exposed to heightened TCR stimulation by self-antigens in the periphery. Importantly, Foxp3 binds to a number of enhancers that become accessible in response to TCR activation, making it difficult to distinguish TCR-activated from Foxp3-activated genes. The analysis is further complicated by the fact that Foxp3 regulates many genes involved in TCR signaling. Interestingly, when comparing wild-type Treg cells to Treg cells that have undergone acute Cre-mediated deletion of a loxP-site-flanked Foxp3 allele, Foxp3-bound sites are enriched only for down-regulated genes. Thus, when Treg-cell activation status is factored in, Foxp3 appears to act predominantly as a repressor (Fig. 1) . This notion is consistent with reports of Foxp3 acting as a repressor when transfected into a T-cell hybridoma line (Marson et al. 2007 ) and in in vitro luciferase reporter assays (Schubert et al. 2001; Beyer et al. 2011; Tai et al. 2013) . It is important to emphasize that Foxp3 likely contributes to up-regulation of many Treg-cell-specific genes by acting in an indirect manner.
Consistent with the evidence from genomics studies supporting a predominant role for Foxp3 as a repressor, biochemical and mass-spectrometric analyses showed that Foxp3 forms large multiprotein complexes containing several major transcriptional repressors, including the nucleosome remodeling deacetylase (NuRD) complex, the nuclear receptor co-repressor (NCOR) complex, and the Polycomb repressive complex (PRC) ). These nuclear factors are likely candidates to mediate Foxp3-dependent target gene repression. In addition to coregulators, Foxp3 also interacts with many other sequence-specific transcription factors including Ets family members, Runx, Bcl11b, and GATA3, which are known to be required for Treg-cell differentiation and function (Rudra et al. 2009 Mouly et al. 2010; Vanvalkenburgh et al. 2011) . Some of these proteins are present at Foxp3-bound sites before Foxp3 induction and may facilitate Foxp3 recruitment (Samstein et al. 2012a ). For instance, Foxp3 binding to its own enhancer, CNS2, is Runx/Cbfb dependent (Zheng et al. 2010) . However, the contribution of these factors to genome-wide Foxp3 localization remains unknown. Further evidence that specific protein interactions are important for Foxp3 function comes from analysis of mice carrying a Foxp3 fusion protein with an amino-terminal insertion of GFP (Bettini et al. 2012; Darce et al. 2012) . Foxp3-based protein -protein interactions appear perturbed in these mice, which show changes in the Treg-cell transcriptional program and modified predisposition to autoimmunity.
An interesting question is how additional external cues are integrated into the Foxp3-dependent and -independent transcriptional and epigenetic program of Treg cells. Treg cells can adapt their suppressive functions to their environment by coexpressing effector T-cell-specific transcription factors (Koch et al. 2009 ). For example, Treg cells can express T-bet to promote efficient suppression of Th1 responses. T-bet induces expression of a small Figure 1 . Gene expression and epigenetic changes during Treg-cell differentiation. Treg cells differentiate from peripheral naive CD4 T cells or CD4SP thymocytes. These cells express low levels of Treg signature genes such as CD25, CTLA4, and GITR and show a closed chromatin conformation at a portion of the sites occupied by Foxp3 in Treg cells. Foxp3-bound genes overlap with both up-and down-regulated genes in Treg cells as compared to naive CD4 T cells and CD4SP thymocytes. Upon receiving appropriate induction signals, these early precursors initiate Treg differentiation that can be subdivided in a Foxp3-independent and a Foxp3-dependent phase. Foxp3
GFPKO reporter null-allele-expressing cells have completed only the Foxp3-independent phase and have already upregulated most Treg "signature" genes. Enhancers of Foxp3 target genes are rendered accessible at this stage by the cooperative activity of chromatin modifying enzymes and TCR-induced transcription factors, including several Foxp3 interaction partners. Following its induction, Foxp3 is recruited to these preaccessible sites, resulting in target gene repression. portion of the Th1 transcriptional program, including chemokine receptors that would allow Treg cells to migrate to the site of inflammation. This paradigm also applies to Treg-mediated suppression of other types of inflammation in both lymphoid and nonlymphoid tissues (Chaudhry and Rudensky 2013) . It will be interesting to determine how Foxp3 interacts with other lineage-specifying transcription factors expressed in the same cell to acquire specialized functions while maintaining Treg identity.
CONCLUDING REMARKS
Foxp3 gene expression is controlled by several regulatory elements that operate at distinct stages of Treg-cell development and perform nonredundant biological functions; however, the molecular mechanisms through which these elements act are still not fully understood. Recent studies have implicated many DNA sequence-specific transcription factors bound to the Foxp3 promoter and enhancers in induction or maintenance of Foxp3 gene expression. Although deficiency in these factors can sometimes duplicate or resemble the functional consequences of deleting the regulatory element to which they bind, a direct demonstration of functional significance of these interactions in vivo should increase our understanding of the mechanisms that regulate Foxp3 gene expression and Treg-cell-fate decisions. Disrupting distinct proximal and distal Foxp3 regulatory elements responsible for different aspects of Foxp3 gene expression in mice may also provide novel insights into Treg-cell biology. For example, our studies of CNS1-deficient mice have showed the nonredundant role of pTreg cells in controlling allergic-type inflammation at mucosal interfaces and in maintaining fetal -maternal tolerance Samstein et al. 2012b ).
Foxp3 shapes the Treg transcriptional program by engaging a TCR-dependent preformed chromatin landscape, where it acts predominantly as a repressor of its direct targets. An important function of Foxp3 may be to repress the activation-induced effector T-cell gene expression program, while still enabling activation-induced proliferation, expression of inhibitory molecules, and homing capabilities. This is in contrast to lineage-specifying transcription factors that act at earlier stages of hematopoietic development, exemplified by PU.1, which actively remodels the chromatin landscape to establish the enhancer repertoire on which activation-induced factors can act (Ghisletti et al. 2010; Heinz et al. 2010; Mercer et al. 2011) . Whether it is a general rule that earlylineage-specification factors acting at major branch points of cellular differentiation remodel chromatin, whereas late-acting factors that make relatively small adjustments to the overall phenotype of the cell act on preformed enhancers, remains to be determined.
